Home » Stocks » TLGT

Teligent, Inc. (TLGT)

Stock Price: $0.566 USD 0.022 (4.01%)
Updated November 23, 4:00 PM EST - Market closed
After-hours: $0.570 +0.004 (0.76%) Nov 23, 7:59 PM

Stock Price Chart

Key Info

Market Cap 3.05M
Revenue (ttm) 55.47M
Net Income (ttm) -53.58M
Shares Out 5.39M
EPS (ttm) -9.89
PE Ratio n/a
Forward PE 6.29
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day November 23
Last Price $0.566
Previous Close $0.544
Change ($) 0.022
Change (%) 4.01%
Day's Open 0.584
Day's Range 0.545 - 0.590
Day's Volume 2,451,172
52-Week Range 0.455 - 6.900

More Stats

Market Cap 3.05M
Enterprise Value 193.28M
Earnings Date (est) Mar 9, 2021
Ex-Dividend Date n/a
Shares Outstanding 5.39M
Float 5.27M
EPS (basic) -9.86
EPS (diluted) -9.89
FCF / Share -4.42
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 744,506
Short Ratio 0.30
Short % of Float 14.13%
Beta 1.72
PE Ratio n/a
Forward PE 6.29
P/FCF Ratio n/a
PS Ratio 0.05
PB Ratio 5.05
Revenue 55.47M
Operating Income -28.39M
Net Income -53.58M
Free Cash Flow -24.75M
Net Cash -190.23M
Net Cash / Share -35.28
Gross Margin 23.01%
Operating Margin -51.18%
Profit Margin -96.60%
FCF Margin -44.61%
ROA -6.49%
ROE n/a
ROIC -9.40%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (1)

Buy 0
Overweight 0
Hold 1
Underweight 0
Sell 0

Analyst Consensus: Hold

Price Target

Current: $0.566
Target: 20.00
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth0.05%9.41%-4.46%42.4%31.15%85.14%112.82%9.7%28.09%-
Gross Profit23.5222.3927.3734.6921.3216.796.152.782.261.11
Operating Income-8.02-15.10-11.802.54-3.193.91-0.08-3.14-2.97-3.63
Net Income-25.12-36.26-15.19-11.996.675.25-0.08-3.93-3.01-3.42
Shares Outstanding5.385.365.335.315.294.984.353.983.942.38
Earnings Per Share-4.70-6.80-2.80-2.30-0.700.90-0.30-1.00-0.80-2.00
Operating Cash Flow-18.42-13.280.40-0.45-15.51-3.89-0.62-2.37-2.39-3.01
Capital Expenditures-8.20-25.29-40.43-16.66-6.00-0.83-0.29-0.34-0.35-0.16
Free Cash Flow-26.62-38.57-40.03-17.10-21.51-4.73-0.91-2.72-2.74-3.17
Cash & Equivalents15.7112.6026.6966.0187.191592.102.542.975.12
Total Debt1871541211111031043.021.020.570.10
Net Cash / Debt-171-141-94.29-45.39-15.8455.28-0.911.522.405.02
Book Value-5.3118.4244.7556.6766.7639.137.196.437.7710.35
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Teligent, Inc.
Country United States
Employees 252
CEO Timothy B. Sawyer

Stock Information

Ticker Symbol TLGT
Stock Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Unique Identifier NASDAQ: TLGT


Teligent, a specialty generic pharmaceutical company, develops, manufactures, markets, and sells generic topical, branded generic, and generic injectable pharmaceutical products in the United States and Canada. The company offers generic pharmaceutical products in topical, injectable, complex, and ophthalmic dosage forms. It is also involved in contract manufacturing and development business, including the development, manufacturing, filling, and package of topical semi-solid and liquid products for branded and generic pharmaceutical customers, as well as for over-the-counter and cosmetic markets. The company's topical semi-solid and liquid products are used in various applications that range from cosmetics and cosmeceuticals; and the prescription treatment of conditions, such as dermatitis, psoriasis, and eczema. It sells its products through national chain drug stores, drug wholesalers, distributors, and group purchasing organizations. The company was formerly known as IGI Laboratories, Inc. and changed its name to Teligent, Inc. in October 2015. Teligent, Inc. was founded in 1977 and is based in Buena, New Jersey.